Early stage breast cancer Cancer Malignant neoplasm of breast
Conditions
Interventions
The study will be a multi-center, cluster randomized trial (cRCT), with hospitals as the unit of randomization (clusters). Four hospitals have agreed to participate in this study. Because of the limit
Sponsors
KWF, The Dutch Cancer Society
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female outpatients who visit to the hospital with breast symptoms, suspected of having breast cancer 2. Age 18 years or older
Exclusion criteria
Exclusion criteria: 1. Presence of major psychiatric disorders (presence of consultation history/record with the psychiatric department) 2. Inadequate command of the Indonesian language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic delay, defined as the number of days between the date of the first consultation at the hospital and the date of final breast cancer diagnosis based on pathological examination | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Breast cancer knowledge measured using the Breast Cancer Knowledge Test (BCKT) at baseline, 7 days and 3 months after finishing PERANTARA 2. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) at baseline, 7 days and 3 months after finishing PERANTARA 3. Quality of life measured using the WHO Quality Of Life-BREF (WHOQOL-BREF) and the European Quality of Life 5D-5L at baseline, 7 days and 3 months after finishing PERANTARA | — |
Countries
Indonesia
Outcome results
None listed